Pervasis Therapeutics explores endothelial cell-based approach to cancer

Pervasis Therapeutics Inc of Cambridge Massachusetts has announced plans to pursue an endothelial cell-based therapy to target and regulate cell stroma in order to prevent solid tumour growth and metastasis.